Latest Derivatives News

Venus Metals Corporation has announced a significant JORC 2012 compliant Exploration Target for zinc and indium at its Youanmi Base Metals Project, with plans for extensive drilling in 2026 to advance the project.

Liberty Metals has announced a significant discovery of high-grade monazite mineralisation rich in critical rare earth elements at its Paraiba Rutile and Monazite Project in Brazil, opening new avenues for exploration and processing.

Great Northern Minerals has reported promising initial antimony assay results from its newly acquired Catalyst Ridge Project and secured a patent option for advanced rare earth flotation technology from the University of Arizona.

Spheria Emerging Companies Limited announces a fully franked 3.8 cents per share quarterly dividend for December 2025 and initiates monthly dividends of 1.3 cents for February and March 2026 as it transitions dividend payments from quarterly to monthly.

ABx Group has extended its rare earth discovery in northern Tasmania with new scout drilling revealing high-grade mineralisation rich in critical heavy rare earths. Positioned near surface and aligned with Australia’s Critical Minerals Strategic Reserve, ABx’s findings could reshape supply chains for these vital elements.

Haranga Resources reports steady progress on its Lincoln Gold Project drilling program in California, despite weather-related dewatering setbacks. Initial assay tests validate the high-grade nature of the resource, setting the stage for an updated JORC-compliant resource estimate.

Rent.com.au has achieved a record quarterly revenue exceeding $1 million, driven by strong recurring income from its RentBond® and RentPay products. This milestone underscores the company’s evolving business model and solid financial footing.

Jupiter Energy reported steady oil production and US$1.6 million in domestic sales for Q4 2025, while completing integration of its West Zhetybai oilfield into a regional gas utilisation network.

Orthocell has increased its investment in Marine Biomedical to 11.7%, securing exclusive distribution rights to the innovative PearlBone™ technology as it nears FDA approval.

Eclipse Metals has initiated metallurgical testing on its Grønnedal Rare Earths Project in Greenland, focusing on magnetic separation techniques to unlock the deposit’s potential. Core samples from recent drilling are en route to Perth for analysis, while strategic engagement with global partners continues.

NeuroScientific Biopharmaceuticals reports encouraging clinical responses in fistulising Crohn’s disease patients treated under Australia’s Special Access Scheme, setting the stage for pivotal Phase 2 trials later this year.

GQG Partners reported a slight decline in funds under management to USD 163.9 billion at the end of 2025, despite significant net outflows, buoyed by strong investment performance throughout the year.